In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
400 News Items found
A Fred’s Team runner giving a high five
Your Impact: Celebrating Our Donors’ Support in 2021

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
Memorial Sloan Kettering surgeon Prasad Adusumilli
Q&A
CAR T Cell Therapy Shows Promise for Treating Mesothelioma

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
a lab coat hangs in an MSK lab
MSK Research Highlights, March 20, 2026

New MSK research discovers a new approach that could prevent chemotherapy-related leukemia; shows how monoclonal antibodies can turn neutrophils into cancer killers; helps develop sensitive CAR T cells that target CD70 antigen to destroy cancer cells; and uses single-cell studies to yield new clues about a rare, aggressive pediatric sarcoma.
Female doctor in white coat examining patient with stethoscope.
Feature
Shorter, Safer, Smarter: How MSK Enhances Radiation Therapy for Breast Cancer

MSK leads the way in optimizing radiation treatment for breast cancer patients.
José Baselga
Announcement
News from #AACR16: Precision Medicine Progress, Turbocharged CARs, and Turning Up the Heat against Cancer

At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.
Immune cells surrounding a cancer cell
In the Lab
Checkpoint Challenge: When Releasing Immune Cell Brakes Is Not Enough to Stop Cancer

Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.
A liquid being pipetted into a well plate.
Meet the 2026 Graduates of the Gerstner Sloan Kettering Graduate School

Fifteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 13, 2026, as part of Memorial Sloan Kettering’s 47th annual academic convocation.
ContactTracing graphic
New Research Shows How Cancer Rewires a Key Immune Pathway To Spread

A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
Radiation oncologist Josh Yamada
Radiation Reimagined: How MSK Experts in Radiation Oncology Are Transforming Care for Metastatic Cancer

Learn how radiation oncologists at Memorial Sloan Kettering are making radiation therapy for metastatic cancer more effective, with fewer side effects, including a new advance called ECHO.
Students pose with Memorial Sloan Kettering President Harold Varmus after the symposium.
Major Trends in Modern Cancer Research

The third annual research symposium introduces high school students and teachers to several topics in cancer research.